DGCI sought an immediate reply, saying else "it shall be construed that you have no explanation to offer and action will be taken"
10 Sep 2020 10:29 AM
The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India
03 Aug 2020 9:09 AM
The product is available from July 29 at all retail medical outlets across the country and will be sold only on prescription, it said
29 Jul 2020 2:04 PM
Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients
21 Jul 2020 3:38 PM
CEO of Biophore said all starting materials for making favipiravir are either sourced locally or have been developed in-house for use
15 Jul 2020 6:59 AM
The drug will be available in 100 mg vial which will be administered intravenously in a hospital under healthcare practitioner supervision
21 Jun 2020 2:45 PM
According to a pharma industry body, Indian pharma companies secure 70-75 per cent of APIs from China.
08 Jan 2018 2:06 AM